Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000465042 | SCV000559400 | likely benign | Rhabdoid tumor predisposition syndrome 2 | 2024-01-18 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000564707 | SCV000664110 | likely benign | Hereditary cancer-predisposing syndrome | 2015-09-19 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Sema4, |
RCV000564707 | SCV002532790 | likely benign | Hereditary cancer-predisposing syndrome | 2021-11-08 | criteria provided, single submitter | curation | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV003478026 | SCV004220393 | likely benign | not provided | 2022-11-03 | criteria provided, single submitter | clinical testing |